Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

The Mary Bradley Show

  • Broadcast in Health
  • 0 comments
Mary Boyle Bradley

Mary Boyle Bradley

×  

Follow This Show

If you liked this show, you should follow Mary Boyle Bradley.
h:56584
s:588134
archived
Julia Schopick from www.honestmedicine.com put Low Dose Naltrexone in perspective in relation to other effective therapies that get overlooked for similar reasons. LDN has the most people power behind it and so must set a precedent for other therapies. Julia spoke about the four therapies she is currently writing about for her upcoming book, LDN being one of them. She believes that to get LDN to the masses it will without doubt be up to the people power supporting it. A must listen folks because Julia describes LDN in the context of other effective therapies and even there .. it is leading the pack. Julia is emphatic that the LDN movement must lose the term "anecdotal" because 100,000 patients is not anecdotal and causes us to lose credibility. She prefers the term Patient Evidence Based Medicine. PEBM gives LDN the credibility it deserves and has earned and will help increase the people power needed to get our elected representatives to take us seriously. I look forward to reading Julia's new book!

Comments

 comments